Anti-Helicobacter pylori antibody status is associated with cancer mortality: A longitudinal analysis from the Japanese DAIKO prospective cohort study

Anti-Helicobacter pylori antibody status is associated with cancer mortality: A longitudinal analysis from the Japanese DAIKO prospective cohort study

Show other versions (1)

Paradoxically, patients with advanced stomach cancer who are Helicobacter pylori-positive (HP+) have a higher survival rate than those who are HP-. This finding suggests that HP infection has beneficial effects for cancer treatment. The present study examines whether HP+ individuals have a lower lik...

Full description

Bibliographic Details
Main Authors: Satoshi S. Nishizuka, Masahiro Nakatochi, Yuka Koizumi, Asahi Hishida, Rieko Okada, Sayo Kawai, Yoichi Sutoh, Keisuke Koeda, Atsushi Shimizu, Mariko Naito, Kenji Wakai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022139/?tool=EBI

Similar Items

Similar Items